Moreover, the expression of ROR1 by cancer cells has been associated with enhanced cancer cell migration, epithelial–mesenchymal transition (EMT), increased risks of relapse and/or metastasis, and an unfavorable prognosis relative to that of cancers that do not express ROR1 [9,10,11,12]. This evidence concerns the gene ROR1 and cancer.